This article was originally published in The Tan Sheet
Teva is in "advanced discussions" with Novopharm regarding its agreement to purchase the Canadian generic manufacturer. Teva, an Israeli pharmaceutical firm that does 80% of its business in the U.S. and Europe, says the deal will involve shares of its stock
You may also be interested in...
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
Combe sells most of its OTC brands
Perrigo promotes in pricing, planning